52
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editors

Sustained improvement in IPEX-like syndrome course following failed umbilical cord blood transplantation

, , , &
Pages 246-249 | Received 21 Jun 2023, Accepted 17 Oct 2023, Published online: 29 Oct 2023

References

  • Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27(1):68–73. doi:10.1038/83784.
  • Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20–21. doi:10.1038/83713.
  • Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4 + CD25+ T regulatory cells. Nat Immunol. 2003;4(4):337–342. doi:10.1038/ni909.
  • Barzaghi F, Amaya Hernandez LC, Neven B, et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study. J Allergy Clin Immunol. 2018;141(3):1036–1049.e5. doi:10.1016/j.jaci.2017.10.041.
  • Gambineri E, Ciullini Mannurita S, Hagin D, et al. Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Front Immunol. 2018;9:2411. doi:10.3389/fimmu.2018.02411.
  • Bin Dhuban K, Piccirillo CA. The immunological and genetic basis of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Curr Opin Allergy Clin Immunol. 2015;15(6):525–532. doi:10.1097/ACI.0000000000000214.
  • Kanai T, Jenks J, Nadeau KC. The STAT5b Pathway Defect and Autoimmunity. Front Immun. 2012;3:1,2. doi:10.3389/fimmu.2012.00234.
  • Angulo I, Vadas O, Garçon F, et al. Phosphoinositide 3-Kinase δ gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342(6160):866–871. doi:10.1126/science.1243292.
  • Goudy K, Aydin D, Barzaghi F, et al. Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity. Clin Immunol. 2013;146(3):248–261. doi:10.1016/j.clim.2013.01.004.
  • Uzel G, Sampaio EP, Lawrence MG, et al. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation–polyendocrinopathy–enteropathy–X-linked–like syndrome. J Allergy Clin Immunol. 2013;131(6):1611–1623.e3. doi:10.1016/j.jaci.2012.11.054.
  • Deau MC, Heurtier L, Frange P, et al. A human immunodeficiency caused by mutations in the PIK3R1 gene. J Clin Invest. 2014;124(9):3923–3928. doi:10.1172/JCI75746.
  • Lucas CL, Kuehn HS, Zhao F, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15(1):88–97. doi:10.1038/ni.2771.
  • Haapaniemi EM, Kaustio M, Rajala HLM, et al. Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. Blood. 2015;125(4):639–648. doi:10.1182/blood-2014-04-570101.
  • Jamee M, Zaki-Dizaji M, Lo B, et al. Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-LINKED (IPEX) and IPEX-like syndrome. J Allergy Clin Immunol Pract. 2020;8(8):2747–2760.e7. doi:10.1016/j.jaip.2020.04.070.
  • Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001;27(1):18–20. doi:10.1038/83707.
  • Attridge K, Walker LSK. Homeostasis and function of regulatory T cells (Tregs) in vivo : lessons from TCR ‐transgenic Tregs. Immunol Rev. 2014;259(1):23–39. doi:10.1111/imr.12165.
  • Karagüzel G, Polat R, Abul MH, Cebi AH, Orhan F. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in two siblings: same mutation but different clinical manifestations at onset. Jcrpe. 2022;14(3):361–365. doi:10.4274/jcrpe.galenos.2021.2021.0005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.